New marker offers hope for more reliable detection of prostate cancer
2011-05-10
(Press-News.org) A new, promising marker for diagnosing prostate cancer has been discovered by Uppsala researchers with the aid of a unique method developed at the Department of Immunology, Genetics and Pathology. The study, being published this week in the journal Proceedings of the National Academy of Sciences, PNAS, can lead to more reliable diagnoses and fewer unnecessary operations.
The PSA marker used for diagnosing prostate cancer today has been criticized for false positive responses, leading to unnecessary operations. There is therefore great interest in finding new and better biomarkers.
- In the limited patient material examined in our study, blood levels of so-called prostasomes seem to correlate more closely with the severity of the disease than do PSA levels, says Masood Kamali-Moghaddam, a scientist in Professor Ulf Landegren's research team at the Department of Immunology, Genetics, and Pathology.
The team has previously developed a uniquely specific and sensitive method, called proximity ligation, for effective determination of proteins, and the method has now been adapted for detecting prostasomes.
One of the co-authors of the present study, Professor Gunnar Ronquist, showed 30 years ago that prostate cells pump out large quantities of a tiny membrane-coated particle in semen, which he named prostasomes. The hypothesis is that, in cancer, rather than winding up in semen, prostasomes are pumped out into the surrounding cancer tissue in invasive cancer. Therefore, prostasomes could be expected to occur at elevated levels in blood in cases of prostate cancer.
It has not been possible earlier to detect prostasomes in blood, but the researchers devised a unique test that requires several different antibodies to simultaneously recognize proteins on the surface of the prostasomes, and this allowed them to detect elevated levels of prostasomes in the blood of patients with prostate cancer.
"We are hopeful that this type of marker will prove valuable not only for prostate cancer but also in several other common tumor types," says Masood Kamali- Moghaddam.
INFORMATION: END
ELSE PRESS RELEASES FROM THIS DATE:
2011-05-10
BOSTON – More than a third of Americans use some form of complementary and alternative medicine (CAM) and that number continues to rise attributed mostly to increases in the use of mind-body therapies (MBT) like yoga, meditation and deep breathing exercises.
Prior research suggests that MBT, while used by millions of patients, is still on the fringe of mainstream medical care in America. New research suggests that attitudes are changing.
In a study from Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School, researchers found that one in 30 Americans ...
2011-05-10
Scientists at Royal Holloway, University of London and the University of Leicester have discovered animals searching for food do not stick to a complicated pattern of movement as previously thought but tend to wander about randomly.
It was previously believed that when searching for food, animals move in very peculiar way called a Lévy flight where they move small distances most of the time, but occasionally move a very long distance.
This idea was based on studies in which many animals, like albatrosses or sharks, were tracked. However scientists have been analysing ...
2011-05-10
Mild cognitive impairment, dementia, and their subtypes are common in the "oldest old" women, which includes those 85 years of age and older, according to a report in the May issue of Archives of Neurology, one of the JAMA/Archives journals.
The oldest old is "the fastest growing segment of the U.S. population and is expected to increase in number by 40 percent during the next decade alone," the authors write as background information in the article. "Initial evidence suggests that the incidence of all-cause dementia almost doubles with every 5 years of age and that the ...
2011-05-10
The available evidence is insufficient to draw firm conclusions about the association of modifiable factors and risk of Alzheimer's disease (AD), according to a report posted online today that will appear in the September issue of Archives of Neurology, one of the JAMA/Archives journals.
Estimates suggest that up to 5.3 million people in this country may have AD, and this number will likely increase as baby boomers grow older. In fact, "age is currently the strongest known risk factor for AD," write the authors. Variation in the apolipoprotein E (APOE) gene is also associated ...
2011-05-10
Elevated pressure inside the eye, cornea thinning, and visual field loss are all markers that glaucoma may progress, according to a report in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Glaucoma is one of the world's leading causes of permanent vision loss. It is a group of diseases that can lead to damage of the optic nerve and can result in vision loss and blindness. Previous studies of glaucoma risk factors do not always represent the majority of patients or real-world practices in treating them. "The purpose of our study is to verify ...
2011-05-10
When infants' tear ducts are blocked, the decision about when to intervene and the cost-effectiveness of doing so depend on how likely it is the problem will self-resolve, according to a report in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
It is not uncommon for babies to be born with blockage of the tear ducts, a condition known as congenital nasolacrimal duct obstruction (NLDO). In many cases, the condition will resolve spontaneously by the time a child is one year old. For affected infants at least six months old, physicians can ...
2011-05-10
Among Medicare beneficiaries, a large portion of colonoscopies for screening purposes are performed more frequently than recommended intervals. But among older patients treated at Veterans Affairs facilities, warranted follow-up colonoscopies for patients with positive fecal blood tests often do not occur, or cause burden when they do. These findings are from two reports posted online today that will appear in the August 8 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Colonoscopy, a screening test used for the detection of colorectal ...
2011-05-10
ASG Bowl, the Official Insurance Partner of Strike Ten Entertainment and the leading distributor of strategic insurance solutions for bowling proprietors nationwide, has announced an exclusive partnership with Walmart to offer discounted prescription pharmaceuticals to bowling proprietors.
The program provides bowling center employees with access to more than 300 different prescription pharmaceuticals for just $4/prescription with a 30-day supply, and only $10/prescription with a 90-day supply. Prescription drugs that are currently not included in the program will still ...
2011-05-10
The introduction of multidetector row computed tomographic pulmonary angiography (CTPA) was associated with an apparent increase in the diagnosis of pulmonary embolism (PE), but with only minimal changes in mortality (death), suggesting the possibility of overdiagnosis, according to a report in the May 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. This article is part of the Less Is More series in the journal.
Pulmonary embolism usually occurs when a blood clot blocks a blood vessel in the lungs. If not treated, PE can be fatal. Therefore, ...
2011-05-10
Commercial funding of continuing medical education (CME) and the potential for bias appear to concern many health care practitioners and researchers, but many reported being unwilling to pay higher fees to eliminate or offset commercial funding sources, according to a report in the May 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Although over the past several years, the role of pharmaceutical and medical device manufacturers in directing CME has been reduced, these entities still fund a substantial proportion of costs. Organizations such ...
LAST 30 PRESS RELEASES:
[Press-News.org] New marker offers hope for more reliable detection of prostate cancer
